irritable bowel syndrome

FDA approves Actavis, Valeant drugs for irritable bowel syndrome
FDA approves Actavis, Valeant drugs for irritable bowel syndrome
Yahoo/Reuters
FDA
Actavis
Valeant Pharmaceuticals
IBS
irritable bowel syndrome
Xifaxan
Viberzi
Flag link:
Takeda targets gastrointestinal disease with its latest R&D deal
Takeda targets gastrointestinal disease with its latest R&D deal
Fierce Biotech
Takeda
R&D
irritable bowel syndrome
Flag link:
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Ardelyx
IBS
irritable bowel syndrome
tenapanor
AstraZeneca Pharma India
Flag link:
Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A
Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A
Bloomberg
Salix
Furiex Pharmaceuticals
M&A
eluxadoline
irritable bowel syndrome
Flag link:
Furiex Said to Seek Buyer as Experimental Drug Meets Targets
Furiex Said to Seek Buyer as Experimental Drug Meets Targets
Bloomberg
Furiex Pharmaceuticals
eluxadoline
M&A
irritable bowel syndrome
Flag link:
Pipeline Progress at Synergy Pharma
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Synergy Pharmaceuticals
irritable bowel syndrome
plecanatide
Flag link:
Ironwood's Bowel Drug Sales Disappoint
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
Flag link:
SP-333 Targets Root Cause Of Irritable Bowel Syndrome
SP-333 Targets Root Cause Of Irritable Bowel Syndrome
Motley Fool
SP-333
irritable bowel syndrome
Synergy Pharmaceuticals
Flag link:
10 Drugs Approved by the FDA in 2012 to Be Thankful For
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Flag link:
Sucampo Announces Approval for Updates to AMITIZA; Endo Health Solutions Stock Halted Following News
Sucampo Announces Approval for Updates to AMITIZA; Endo Health Solutions Stock Halted Following News
Equities.com
Sucampo
Amitiza
Endo Health Solutions
irritable bowel syndrome
Flag link:
Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)
Sucampo Pharmaceuticals, Inc. : Sucampo Presents Data for AMITIZA® in the Treatment of Moderate to Very Severe Irritable Bowel Syndrome with Constipation (IBS-C)
4-Traders
Sucampo
Amitiza
irritable bowel syndrome
Flag link:
Yet Another Delay for Forest Labs
Yet Another Delay for Forest Labs
Yahoo/Zacks
Forest Labs
Ironwood Pharmaceuticals
linaclotide
irritable bowel syndrome
Flag link:
Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Fierce Biotech
Tioga
venture capital
D-IBS
irritable bowel syndrome
Series B
asimadoline
Flag link:
FDA gives fast-track status to Tioga irritable bowel drug
FDA gives fast-track status to Tioga irritable bowel drug
San Diego Union Tribune, CA
irritable bowel syndrome
FDA
IBS
Tioga
fast track
Flag link:
Salix's IBS drug fails to get FDA nod
Salix's IBS drug fails to get FDA nod
Reuters
FDA
Salix
IBS
irritable bowel syndrome
Xifaxan
Flag link:
Salix Tanks After Drug Setback
Salix Tanks After Drug Setback
Minyanville
Salix
Xiafaxan
IBS
irritable bowel syndrome
Flag link:
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Morningstar
Lexicon Pharmaceuticals
LX2931
arthritis
LX1032
carcinoid syndrome
LX1031
irritable bowel syndrome
Flag link:
Ironwood, Forest boast positive IBS drug trial
Ironwood, Forest boast positive IBS drug trial
Yahoo/AP
IBS
irritable bowel syndrome
Ironwood
Forest Labs
linaclotide
Flag link:
Lexicon says IBS drug met mid-stage study goal
Lexicon says IBS drug met mid-stage study goal
Yahoo/AP
IBS
irritable bowel syndrome
Lexicon Pharmaceuticals
Flag link: